PSB is being developed by Pooya Paridel.
صفحه اول
 
Amin Pharm. ( AMIN1 ) -  Instrument state code : Authorized -  End of consultation  -  19:46:53 .
Closing Price 12,600 Yesterday Price 12,700 Number Of Trades 211 EPS
-100     (%-0.79) Maximum Price 12,080 Trade Value 7,381,841,170 P/E
Last traded price 12,070 Minimum Price 12,070 Number Of Traded Shares 611,574 Max Authorized Price 2,624
-630     (%-4.96) First Price 12,070 Base Volume 3,968,254 Min Authorized Price 2,472
Last Trade Date 1399/8/7 - 12:28:17   Market Cap (milion IRR) 17,010,000 Number of Shares 1,350,000,000
BuySell
No #QuantityPricePriceQuantityNo #
1 100 5,000 12,070 298,749 28
0 0 0 12,080 42,543 1
0 0 0 12,300 15,223 2


.
PublishDate FinantialPeriod EPS
Estimated EPS Estimated PreEPS Actual EPS Actual PreYear EPS Actual PrePriod EPS

Related Companies - Name Last Traded Price Number Of Trades Number of Traded Shares Trades Value
G.Barekat Pharm (BRKT1) 13,650 (-1.30%) 14051 61619294 814928187260
S*Alborz Inv. (ALBZ1) 13,920 (-2.86%) 1492 7686308 105578365980
Rishmac Prod.&EXP (RPEZ1) 32,734 (5.00%) 1116 3689742 119899780377
Kowsar Pharm. (DKSR1) 19,800 (-4.49%) 842 2032439 40224935170
Tamin Daroo (DTIP1) 48,690 (4.69%) 787 994508 48031977430
Zahravi Phar. (DZAH1) 10,330 (-4.97%) 705 3824961 39516925350
Rahavard PHARMA (RAPZ1) 31,052 (1.77%) 567 763851 23164295759
Ankolojy Sobhan (DSNZ1) 15,744 (-5.00%) 416 1173653 18500535873
Damloran Pharm. (DAML1) 13,040 (-4.96%) 413 1324090 17472955470
Razak Lab. (DRZK1) 32,010 (-4.99%) 409 663746 21397065470

Shareholder Number Of Shares Percent of Shares Changes
شركت داروسازي كوثر-سهامي عام- 514,661,853 38.120
شركت پارس دارو-سهامي عام- 216,026,930 16.000
انجمن خيريه ايتام حضرت اميرالمومنين 40,499,931 2.990
Individual Person 31,783,093 2.350
Individual Person 25,008,188 1.850
Individual Person 23,767,516 1.760
Individual Person 20,249,999 1.490
شركت بيمه مركزي جمهوري اسلامي ايران 19,089,149 1.410
شركت الحاوي-سهامي عام- 17,549,999 1.290
Individual Person 16,874,999 1.240
Individual Person 16,472,043 1.220

Summary